pathophysiology of DUSP22 and MTNR1 gene abnormalities
Project/Area Number |
17K16294
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Pediatrics
|
Research Institution | Institute for Developmental Research Aichi Developmental Disability Center |
Principal Investigator |
HAMADA NANAKO 愛知県医療療育総合センター発達障害研究所, 分子病態研究部, 研究員 (70721835)
|
Project Period (FY) |
2017-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 自閉スペクトラム症 / ASD / Dusp22 / MRTNR / DUSP22 / 自閉症 / 大脳皮質形成 |
Outline of Final Research Achievements |
We examined the role of MTNR1A, 1B and DUSP22 in brain development and the pathophysiological significance of these gene abnormalities. Information of tissue and subcellular distribution of Dusp22 is largely unknown while information on the quality of commercially available antibodies is very limited. Therefore, we here produced a rabbit polyclonal antibody specific for Dusp22 and performed expression analyses of the molecule. While western blotting analyses clarified that Dusp22 was dominantly expressed in heart and skeletal muscle. Dusp22 was diffusely distributed in the cytoplasm and partially colocalized with actin cytoskeleton. Silencing of DUSP22 prevented dendrite development in cortical pyramidal cells in vivo. Knockdown of MTNR1A and 1B did not affected cell morphology.
|
Academic Significance and Societal Importance of the Research Achievements |
これまで全く不明であった自閉症関連遺伝子DUSP22のマウス発達期の組織ごとの発現や細胞内局在について詳細に示すことができた。
|
Report
(5 results)
Research Products
(28 results)
-
-
[Journal Article] Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice.2020
Author(s)
Reut Suliman-Lavie, Ben Title, Yahel Cohen, Hamada N, Maayan Tal, Nitzan Tal, Galya Monderer- Rothkoff, Bjorg Gudmundsdottir, Kristbjorn O Gudmundsson, Jonathan R Keller, Guo-Jen Huang, Nagata K, Yosef Yarom, Sagiv Shifman.
-
Journal Title
Nat. Commun.
Volume: 11
Issue: 1
Pages: 5836-5836
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] MYCN de novo gain-of-function mutation in a patient with a novel megalencephaly syndrome.2018
Author(s)
Kato K, Miya F, Hamada N, Negishi Y, Kishimoto N, Ozawa H, Ito H, Hori I, Hattori A, Okamoto N, Kato M, Tsunoda T, Kanemura Y, Kosaki K, Takahashi Y, Nagata K, Saitoh S.
-
Journal Title
J. Med. Genet
Volume: 0
Pages: 1-8
Related Report
Peer Reviewed
-
[Journal Article] De novo PHACTR1 mutations in West Syndrome and their pathophysiological effects.2018
Author(s)
Hamada N, Ogaya S, Nakashima M, Nishijo T, Sugawara Y, Iwamoto I, Ito H, Maki Y, Shirai K, Baba S, Maruyama K, Saitsu H, Kato M, Matsumoto M, Momiyama T, Nagata K
-
Journal Title
Brain
Volume: 141
Pages: 3098-3114
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-